Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000240·OnKure Therapeutics, Inc.
Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Common Stock · CUSIP: 68277Q105
Event date: 2025-12-31
- Filing-level shares
- 626,593
- Percent of class
- 4.87%
- The Vanguard Group
Shares: 626,593 · Class: 4.87%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000240
- Form type
- SCHEDULE 13G/A
- Filer
- OnKure Therapeutics, Inc.
- CIK
- CIK 1637715
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership